TRVI
Trevi Therapeutics, Inc. · Healthcare
Director Michael Thomas Heffernan sold $596K of Trevi Therapeutics, Inc.
Sold$595,806
$15.09Price
39,473Shares
−86%Stake
What TRVI did after the filing
- The stock from Fri, Sep 18 open, $15.17
- −21.6%
- S&P 500, same days
- +0.7%
21 of 30 trading days so far, to the Oct 19 close.
Traded Tue, Sep 15. Filed Thu, Sep 17, 4:55 PM ET, after the close. Returns use the Sep 18 open and the Oct 19 close. Not investment advice.